2024年12月期 第2四半期決算短信〔IFRS〕（連結）

This document is the consolidated financial results for the second quarter (interim period) of the fiscal year ending December 2024 for GNI Group, Inc. It reports that for the six months ending June 30, 2024, the company achieved revenue of 11,733 million yen, a decrease of 16.8% compared to the same period last year, with operating profit down by 67.8% to 1,762 million yen, and a pre-tax profit of 831 million yen, down 83.8%. The net profit attributable to the parent company was a loss of 73 million yen, compared to a profit of 4,014 million yen in the previous year. Despite the challenging economic environment, the sales of key products remained strong, and there are expectations for upcoming clinical trials and new product developments.